Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Garuda Therapeutics
company
About
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $72M
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$72M
Garuda Therapeutics has raised a total of
$72M
in funding over 2 rounds. Their latest funding was raised on
Sep 23, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 23, 2021 | Series A | $72M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Garuda Therapeutics is funded by 1 investors.
Resilience
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Resilience
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
